Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Summary
To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
150000
Start Date
2017-06-15
Completion Date
2037-06-15
Last Updated
2022-04-08
Healthy Volunteers
Not specified
Conditions
Interventions
directly acting antivirals (DAAs)
Eligible subjects would be those CHC patients who receive approved DAA in the daily practice in Taiwan. No clinical developing medications will be allocated patients.
Locations (1)
HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Kaohsiung City, Taiwan